The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.
Age range
45 Years – 79 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Macrovascular Endothelial function in the fasted condition
Timeframe: 4 weeks
Microvascular endothelial function in the fasted condition
Timeframe: 4 weeks
Microvascular digital endothelial function in the fasted condition
Timeframe: 4 weeks
Macrovascular Endothelial function during acute hyperglycemia
Timeframe: 4 weeks
Microvascular forearm endothelial function during acute hyperglycemia
Timeframe: 4 weeks
Central and peripheral arterial stiffness in the fasted condition
Timeframe: 4 weeks
Central arterial stiffness during acute hyperglycemia
Timeframe: 4 weeks
Blood pressure in the fasted condition
Timeframe: 4 weeks
Blood pressure during acute hyperglycemia
Timeframe: 4 weeks
Total peripheral resistance in the fasted condition.
Timeframe: 4 weeks
Total peripheral resistance during acute hyperglycemia
Timeframe: 4 weeks
Stroke volume in the fasted condition
Timeframe: 4 weeks
Stroke volume during acute hyperglycemia
Timeframe: 4 weeks
24-hour ambulatory blood pressure monitoring
Timeframe: 4 weeks